【导读】聚石化学被中国证监会立案，涉嫌信息披露违法违规 中国基金报记者 卢鸰 聚石化学 11 月 21 日晚公告，公司于 2025 年 11 月 21 日收到中国证监会下发的《立案告 知书》，因公司涉嫌信息披露违法违规，根据《中华人民共和国证券法》《中华人民共和国 行政处罚法》等法律法规，中国证监会决定对公司立案。 降幅为 42.19% ；更正后的基本每股收益为 -1.95 元，比修正前减少 0.77 元，降幅为 65.25% 。 聚石化学当时称，此次更正数据差异的主要原因是：公司 2021 年收购的广东冠臻科技有限 公司经营业绩未达预期、未能完成相关业绩承诺，公司对相关的业绩补偿款计提减值损失 4362 万元；对部分固定资产进行费用化处理，影响金额 1163 万元，无形资产计提减值损 失 2100 万元；对公司循环租赁业务相关固定资产计提减值损失 2175 万元。 此后，聚石化学收到上海证券交易所出具的《关于广东聚石化学股份有限公司 2024 年年度 报告的信息披露监管问询函》，被要求逐项说明各个调整事项的计算方式、原因及合理性， 是否符合企业会计准则的相关规定等；并全面自查是否存在其他会计差错和需要追溯调 ...

Group 1 - The core point of the news is that two companies, 聚石化学 and 豪尔赛, are under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws [2][3] - 聚石化学 reported a revenue of 2.963 billion yuan for the first three quarters of 2025, a year-on-year decrease of 7.17%, and a net profit attributable to shareholders of 5.7684 million yuan, with a net loss of 24.5322 million yuan after deducting non-recurring gains and losses [2] - 豪尔赛 stated that its business operations are normal and that the investigation will not have a significant impact on its management [3] Group 2 - Next week, 38 stocks will face a total unlock market value of 21.678 billion yuan [4] - 南方航空 will have 804 million shares listed for circulation, with an unlock market value of 5.689 billion yuan [5] - 菲菱科思 will have 22 million shares listed for circulation, with an unlock market value of 1.871 billion yuan [6] Group 3 - Among the 38 stocks facing unlock, 6 stocks have a high unlock ratio exceeding 30%, including 必易微, 吉冈精密, 赛恩斯, and 菲菱科思 [8] - The average stock price of the 38 stocks has decreased by 8.22% since November, with 久其软件 showing the highest increase of 13.74% [9] - 6 stocks with reported losses in the first three quarters include 红太阳, 水发燃气, 中望软件, 生物谷, 久其软件, and 必易微, indicating higher unlock pressure [10]

Group 1 - The core point of the article is that both 聚石化学 (Jushi Chemical) and 豪尔赛 (Haosai) have received notices from the China Securities Regulatory Commission (CSRC) regarding investigations into alleged violations of information disclosure laws [2][4] - Jushi Chemical announced that it received a notice from the CSRC on November 21, 2025, indicating that the company is under investigation for suspected information disclosure violations [2] - The company stated that all its business activities are currently operating normally and it will actively cooperate with the CSRC's investigation while fulfilling its information disclosure obligations [4][6] Group 2 - Haosai also received a notice from the CSRC for suspected violations of information disclosure laws and will cooperate with the investigation [4][6] - The company confirmed that its business operations are proceeding normally and that the investigation will not have a significant impact on its management and operations [6]

Group 1: Shareholding Changes - Company Zhaoyi Innovation announced that several directors and senior management personnel plan to reduce their holdings by a total of 249,000 shares, with specific reductions from the vice chairman and general manager, as well as other vice presidents [1] - Company Super Aerospace announced a stock suspension due to its controlling shareholders planning a significant matter that may lead to a change in control [2] - Company Haosai is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws [5] Group 2: Major Contracts and Projects - Company Dajin Heavy Industry's wholly-owned subsidiary signed a contract worth approximately 1.339 billion yuan for a European offshore wind farm project, which represents 35.41% of the company's audited revenue for 2024 [3] - Company Ruifeng New Materials plans to increase capital by 200 million yuan in a related party to advance a lithium hexafluorophosphate project [6] Group 3: Regulatory Actions - Company Jushi Chemical received a notice from the CSRC regarding an investigation for suspected violations of information disclosure laws [4] - Company Huosai is also under investigation by the CSRC for similar reasons [5] Group 4: Investment and Acquisitions - Company Gao Neng Environment plans to acquire 45.2% equity in three mining companies [7] - Company Aerospace Electric intends to purchase 32% equity in Shenzhen Aerospace Electric Motor System Co., Ltd. through public bidding [8]

2025.11. 21 本文字数：501，阅读时长大约1分钟 来源 | 第一财经、证券时报、公司公告 同日， 豪尔赛（002963） 公告，公司于近日收到中国证监会下发的《立案告知书》，因涉嫌信息 披露违法违规，根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证 监会对公司进行立案。 11月21日晚， 聚石化学（688669） 公告称，公司于2025年11月21日收到中国证监会下发的《立 案告知书》，因公司涉嫌信息披露违法违规，中国证监会决定对公司立案。 聚石化学称， 目前公司各项经营活动和业务均正常开展，将积极配合中国证监会的相关工作，并及 时履行信 息披露义务。 第 一 财 经 持 续 追 踪 财 经 热 点 。 若 您 掌 握 公 司 动 态 、 行 业 趋 势 、 金 融 事 件 等 有 价 值 的 线 索 ， 欢 迎 提 供 。 专 用 邮 箱 ： bianjibu@yicai.com （注：我们会对线索进行核实。您的隐私将严格保密。） 推荐阅读 10月新能源新车降价幅度超11% 豪尔赛表示，公司将积极配合中国证监会立案调查工作，并严格按照相关法律法规的规定和监管要求 及时履 ...

聚石化学表示，目前公司各项经营活动和业务均正常开展。立案调查期间，公司将积极配合证监会的相 关工作，并严格按照相关法律法规和监管要求及时履行信息披露义务。 北京商报讯(记者马换换王蔓蕾)11月21日晚间，聚石化学(688669)披露公告称，公司于当日收到证监会 下发的《立案告知书》，因公司涉嫌信息披露违法违规，证监会决定对公司立案。 ...

Group 1 - Daikin Heavy Industries' subsidiary signed a contract worth approximately 1.339 billion yuan for an offshore wind farm project in Europe, accounting for 35.41% of the company's audited revenue for 2024 [1] Group 2 - Zhaoyi Innovation announced that several board members and senior management plan to reduce their holdings by a total of 249,000 shares, due to personal financial needs, with the reduction period set from December 15, 2025, to March 14, 2026 [2] Group 3 - Jushi Chemical received a notice from the China Securities Regulatory Commission regarding an investigation for suspected violations of information disclosure laws, while the company's operations continue normally [3][6] Group 4 - Chaozhuo Aerospace announced a stock suspension due to major matters being planned by its controlling shareholders, which may lead to a change in control [4] Group 5 - Heng Rui Medicine received approval for clinical trials of SHR-1139 injection, a biopharmaceutical with no similar products approved for sale domestically or internationally, with a cumulative R&D investment of approximately 100.13 million yuan [5] Group 6 - Huayou Pharmaceutical's HYP-6589 tablet for treating advanced non-small cell lung cancer received a clinical trial application acceptance notice, with no similar products approved for sale [8] Group 7 - Renfu Pharmaceutical's application for the marketing license of Dexamethasone L-amphetamine capsules was accepted, aimed at treating ADHD, with a cumulative R&D investment of approximately 90 million yuan [10] Group 8 - Huibo Group won a bid for a 1.596 billion yuan project for the restoration of an oil field in Iraq [10]

2家上市公司，公告被证监会立案。 11月21日晚，聚石化学（688669）公告称，公司于2025年11月21日收到中国证监会下发的《立案告知书》，因公司涉嫌信息披露违法违规，中国证监会决定对 公司立案。 聚石化学称，目前公司各项经营活动和业务均正常开展，将积极配合中国证监会的相关工作，并及时履行信息披露义务。 同日，豪尔赛（002963）公告，公司于近日收到中国证监会下发的《立案告知书》，因涉嫌信息披露违法违规，根据《中华人民共和国证券法》《中华人民共和 国行政处罚法》等法律法规，中国证监会对公司进行立案。 值得注意的是，豪尔赛曾于2025年7月29日公告，公司实际控制人之一戴宝林为支持戴聪棋作为上市公司控股股东暨实际控制人行使股东权利，更好地行使公司经 营管理及重大事项决策权，与戴聪棋签署了《关于豪尔赛科技集团股份有限公司之表决权委托协议》，将持有的公司3512.84万股股份（占公司总股本的 23.36%）对应的全部表决权、召集权、提名和提案权、参会权、监督建议权以及除收益权和股份转让权等财产性权利之外的其他权利独家委托给戴聪棋行使。本 次表决权委托后，公司控股股东、实际控制人变更为戴聪棋和刘清梅；戴宝林、 ...

Core Viewpoint - 聚石化学 and 豪尔赛 are both under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, which may impact their operations and investor confidence [1][5]. Company Overview - 聚石化学 specializes in the research, production, and sales of new chemical materials, with products including modified plastic particles, automotive profiles, optical materials, and flame retardants, among others [3]. - 豪尔赛 focuses on technology innovation, developing smart lighting, smart cultural tourism, and smart urban areas, along with a digital twin integration network platform [7]. Financial Performance - 聚石化学 reported a revenue of 986.58 million yuan for Q3 2025, a decrease of 0.81% year-on-year, with a net profit of 2.89 million yuan [4]. - 豪尔赛 achieved a revenue of 106.94 million yuan for Q3 2025, an increase of 31.34% year-on-year, with a net profit of 740.11 thousand yuan, reflecting a significant growth of 599.72% [8].

Core Viewpoint - Two A-share companies, 聚石化学 and 豪尔赛, have been investigated by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws [2][5]. Group 1: 聚石化学 (688669) - On November 21, 2025, 聚石化学 received a notice from the CSRC regarding the investigation for suspected information disclosure violations [2]. - The company reported a revenue of 987 million yuan in Q3 2025, a year-on-year decrease of 0.81%, with a net profit attributable to shareholders of 2.89 million yuan [4]. - 聚石化学 specializes in the research, production, and sales of new chemical materials, with products used in various industries including automotive, electronics, and healthcare [4]. Group 2: 豪尔赛 (002963) - 豪尔赛 also received a notice from the CSRC for suspected information disclosure violations [5]. - The company reported a revenue of 107 million yuan in Q3 2025, a year-on-year increase of 31.34%, and a net profit attributable to shareholders of 7.40 million yuan, a significant increase of 599.72% [8]. - 豪尔赛 focuses on technology innovation in areas such as smart lighting and digital twin networks, and has been under scrutiny due to previous issues related to corporate governance and internal controls [7][8].